EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 424 filers reported holding EXELIXIS INC in Q4 2023. The put-call ratio across all filers is 0.20 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $1,075 | -7.2% | 47,830 | -2.0% | 0.44% | -6.2% |
Q1 2024 | $1,159 | +2.5% | 48,830 | +3.6% | 0.47% | -3.9% |
Q4 2023 | $1,131 | +0.5% | 47,150 | -8.4% | 0.49% | -5.6% |
Q3 2023 | $1,125 | -3.4% | 51,475 | -15.6% | 0.52% | +0.8% |
Q2 2023 | $1,165 | -2.5% | 60,975 | -1.0% | 0.52% | -5.7% |
Q1 2023 | $1,195 | +24.2% | 61,575 | +2.7% | 0.55% | +17.9% |
Q4 2022 | $962 | -99.9% | 59,975 | +5.3% | 0.46% | -0.4% |
Q3 2022 | $893,000 | -25.5% | 56,975 | -1.0% | 0.46% | -20.4% |
Q2 2022 | $1,198,000 | -4.4% | 57,535 | +4.1% | 0.58% | +11.7% |
Q1 2022 | $1,253,000 | – | 55,285 | – | 0.52% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Meditor Group Ltd | 11,275,871 | $254,722,000 | 71.55% |
GREAT POINT PARTNERS LLC | 1,201,100 | $27,133,000 | 5.61% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 886,534 | $20,027,000 | 5.30% |
Sargent Investment Group, LLC | 498,350 | $11,258,000 | 2.96% |
CAPITAL MANAGEMENT CORP /VA | 311,660 | $7,040,000 | 1.57% |
EULAV Asset Management | 2,460,000 | $55,571,000 | 1.49% |
CM Management, LLC | 80,000 | $1,807,000 | 1.34% |
Integral Health Asset Management, LLC | 200,000 | $4,518,000 | 1.29% |
FARALLON CAPITAL MANAGEMENT LLC | 10,750,000 | $242,843,000 | 1.21% |
Sofinnova Investments, Inc. | 839,181 | $18,957,000 | 1.14% |